The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Abrilada
adalimumab-afzb · Kit · A-S Medication Solutions
NDC 50090-8032-00 · 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 1 mL in 1 PACKET · BLA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- BLA761118
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
- Planned discontinuation — Abrilada, Injection, Kit (NDC 0025-0325-01)Oct 9, 2025
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of adalimumab-afzb (Kit)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| A-S Medication Solutions | Jul 15, 2026 | Sep 3, 2026 | |
| Pfizer Laboratories Div Pfizer Inc | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Abrilada — NDC 50090-8032-00," retrieved September 3, 2026, https://drugdashboards.com/drug/50090803200.
Free to cite with attribution — see how the data is put together.